Amarin Corp Plc (AMRN)

[everyonesguess]

Seemingly, AMRN becomes a matured stock. No more jumps like one of 9/24/18.

A BO is still insight. But quite many staffs still sticking around.

First at all, does AMRN interest in a BO (even with fair value)? Or they would like to GIA or partnering? It is not clear as now. For a drug like V, GIA seems too thin in considering of huge PCP market. Partnering is a doable way, but finding a suitable partner is a must. BO may be great but in what term(s). I think that AMRN doesn't have a clear clue yet. Themselves are in searching a suitable way.

Currently, RX number is the only reliable way to give us a glim of commercialization of V. Sam's number doesn't tell us the whole, but his number is stable and reliable to represent the commercialization of V. Much thanks to Sam.

Be patient. The game is in the second inn, though the game changer has already been showing up. Wait and see!